VIM0423 for Isolated Dystonia
A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia
Recruiting
Phase 2
Interventional Study
Dystonia
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 70
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 100 (estimated)
- Sponsor
- Vima Therapeutics · Industry
Who this trial is looking for
This trial is looking for adults with isolated dystonia to help test a new treatment called VIM0423. Participants will receive either VIM0423 or a placebo to see how well it works and if it is safe.
Are You a Good Fit for This Trial?
You may be able to join if
- I am a man or a nonpregnant woman aged 18 to 65 years old.
- I have been diagnosed with isolated dystonia for at least one year.
- I have two or more body regions affected by dystonia.
- I meet the specific scoring requirements for my condition.
You may not be able to join if
- I am pregnant.
- I have not been diagnosed with isolated dystonia.
- I have had certain treatments that do not meet trial criteria.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
Stride Dystonia is a randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety, and tolerability of VIM0423 in individuals with isolated dystonia.
The main objectives of this clinical trial are to determine the following:
* Does VIM0423 therapy improve dystonia symptoms compared to placebo?
* Is VIM0423 well tolerated in individuals with isolated dystonia? and
* Do the …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Participant must be male or nonpregnant female between 18 and 70 years of age (inclusive) at Visit 1 (Screening).
* The participant has a clinical diagnosis of isolated dystonia with symptoms consistent with dystonia for at least one year prior to Visit 1 (Screening); has two …
Contacts